Aptose Biosciences Announces Collaborations for New Multi-Targeting Epigenetic Therapeutic Agents

By: via Benzinga
Aptose Biosciences Inc. (Nasdaq: APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.